Related Experiment Video
Updated: Mar 23, 2026
03:19
Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography
Published on: June 21, 2024
2.7K
Obesity and kidney disease: Beyond the hyperfiltration.
A Mascali1, O Franzese1, S Nisticò2
1Division of Hypertension and Nephrology, Department of System Medicine, University of Rome Tor Vergata, Rome, Italy.
Summary
Overweight and obesity contribute significantly to kidney disease, representing an emerging epidemic. This study explores how obesity directly damages kidneys, independent of diabetes and hypertension.
Area of Science:
- Nephrology
- Endocrinology
- Public Health
Background:
- Overweight and obesity are major contributors to kidney disease in industrialized nations, affecting 13.8% of men and 24.9% of women.
- Obesity-associated glomerulopathy is recognized as an emerging epidemic, highlighting a critical public health concern.
- Kidney function impairment due to obesity occurs through various direct and indirect mechanisms.
Discussion:
- While obesity's link to type 2 diabetes and hypertension is well-known, its role in direct kidney damage is less recognized.
- This paper focuses on the direct impact of obesity on kidney health, independent of common comorbidities.
- The study investigates the specific contribution of adipose tissue, especially visceral fat, to obesity-induced chronic kidney damage.
Key Insights:
- Obesity directly causes kidney damage, irrespective of hypertension and diabetes.
- Visceral adipose tissue plays a crucial role in obesity-related kidney disease.
- Increased awareness of obesity's independent nephrotoxic effects is critical.
Outlook:
- Further research into the mechanisms of direct kidney damage from obesity is warranted.
- Developing targeted interventions for obesity-related kidney disease is a priority.
- Public health strategies should address obesity as a primary driver of chronic kidney disease.
Related Concept Videos
01:28Chronic Kidney Disease III: Interprofessional Care
595
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
595
01:21External Anatomy of the Kidney
4.6K
The kidneys are a pair of bean-shaped organs in the human body that play a critical role in maintaining overall health. They filter out waste products from the blood, regulate blood pressure, maintain electrolyte balance, and stimulate the production of red blood cells.
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
4.6K
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
274
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
274
01:21Drug Dosing: Obese Patients
334
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
334
01:25Chronic Kidney Disease I: Introduction
1.0K
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.0K
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
363
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
363